一个随机的剂量发现研究,用于治疗阻塞性睡眠呼吸暂停的dronabinol和acetazolamide组合
Jennifer Walsh1,2, Timothy Rankin1, Sumit Mehra1,2,3
1Centre for Sleep Science, School of Human Sciences, University of Western Australia, Perth, Western Australia, Australia.
Sleep
|November 26, 2024
概括
一种新的药物组合IHL-42X在临床试验中显著降低了阻塞性睡眠呼吸暂停 (OSA) 的严重程度. 这种药物方法为患有OSA的患者提供了潜在的新治疗选择.
科学领域:
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 治疗通常是无效的或耐受不良.
- 需要对OSA进行替代治疗选择.
- 药品可能为OSA管理提供一个可行的替代方案.
研究的目的:
- 为了评估IHL-42X的疗效和安全性,阿西塔佐胺和德罗纳醇的组合,在治疗OSA.
- 评估低,中,高剂量IHL-42X对OSA严重性的影响.
- 在一项随机,双盲,交叉研究中,将IHL-42X与安慰剂的影响进行比较.
主要方法:
- 患有OSA (AHI ≥15事件/小时) 的参与者每周接受三剂IHL-42X或安慰剂,每周1周,治疗之间有1周的洗期.
- 关键的终点包括从基线的呼吸暂停-呼吸暂停指数 (AHI) 和氧气不和指数 (ODI) 的变化.
- 还监测了爱普沃思睡眠评分 (ESS),情绪和不良事件 (AE).
主要成果:
- 与安慰剂相比,IHL-42X在所有测试剂量中显著降低了AHI (p < .05).
- 与安慰剂相比,IHL-42X的中剂量显示了ODI3%的显著减少 (p < .05).
- 没有观察到ESS或情绪的显著变化;在IHL-42X治疗期间报告了轻度至中度的副作用.
结论:
- 在患有OSA的患者中,一周夜间服用IHL-42X是耐受良好且安全的.
- IHL-42X显著降低了OSA的严重程度,由降低的AHI和ODI表明.
- 这项研究表明,IHL-42X是治疗阻塞性睡眠呼吸暂停的有前途的药物选择.
相关概念视频
01:19Management of Insomnia
231
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
231
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
202
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
202
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146